Diet-induced insulin resistance altered cardiac GLUT4 and FATP/CD36 expression in rats
Beni-Suef University Journal of Basic and Applied Sciences volume 11, Article number: 131 (2022)
Altered substrate transport protein expression is central to the effect of insulin resistance on cardiac metabolism. The present study was thus designed to investigate the comparative effects of high fat, high sucrose and salt-induced IR on cardiac expression of fatty acid transporter (FATP) and glucose transporter (GLUT4) in rats.
Rats fed with high fat, high sucrose and salt diets developed impaired glucose tolerance (p > 0.05) and hyperinsulinemia (p < 0.05) compared with control group. Myocardial glucose transporter expression was significantly increased (p < 0.001 for salt-induced IR; p < 0.01 for sucrose-induced IR; p < 0.01 for fat-induced IR) across all IR groups compared with control. Fatty acid transporter expression was also increased (p < 0.001) in high salt diet-induced IR rats, and high fat diet-induced IR rats (p < 0.05).
Our results demonstrate that salt and not caloric excess has a potential role in IR alteration of myocardial substrate transport protein expression in the rat.
Insulin resistance (IR) is a state in which the cells of the body do not respond properly to the hormone insulin. It is a characteristic feature of metabolic syndrome in a number of disorders such as diabetes mellitus, hypertension, obesity and dyslipidemia . While the exact cause of IR is still not fully understood, factors that could lead to IR include genetic factors, high caloric intake, high carbohydrate intake, chronic stress and a sedentary life style . Since insulin is the most potent anabolic hormone which promotes the metabolism of glucose, fatty acids and amino acids in most tissues of the body , it affects the ability of body tissues to take up major substrates such as glucose and fatty acids for energy production. Cardiac dysfunction is known to be the leading cause of death in type 2 diabetic patients . Central to the effect of IR on cardiac tissue metabolism is altered substrate transport protein expression in cardiac myocytes [5, 6]. The two keys substrate transport protein in the heart include FAT/CD36 and GLUT4 . These two transport proteins are the primary steps in the utilization of their respective substrate for metabolism in the heart. FAT/CD36 is responsible for the uptake of long chain fatty acids into the myocardium, this accounts for about 70% of the energy generated in the healthy heart, while GLUT4 is responsible for the uptake of glucose into the myocardium and accounts for about 20% of the energy generated in the healthy heart . Indeed, the heart is known to be a metabolic omnivore as it can use fatty acids, glucose, lactate and ketone bodies as substrate for energy generation . The heart is flexible in its choice of energy substrate [10, 11] and factors that determine its choice include substrate availability, translocation of substrate transport proteins and metabolic effectors. In postprandial states insulin increases the uptake of glucose in the myocardium from 20% to about 60% [12, 13]. In insulin resistance, there is a reported alteration in the expression of substrate transport protein in the sarcolemma of cardiac myocytes . From the study of Jameel and Zhang , decreased myocardial tissue expression of GLUT4 correlate with insulin resistance that is different from the hyperglycemic whole body insulin resistance and thus suggests that myocardial hypertrophy is associated with its peculiar insulin resistance independent of diabetes. Mechanical stress-induced insulin resistance associated with myocardial hypertrophy along with a significant decrease in GLUT4 expression in rats was also reported by Afolabi et al. . However, it is not clear whether dietary factors leading to insulin resistance (IR) have any influence on the substrate transport protein expression in cardiac tissue. The present study was thus designed to investigate the comparative effects of high fat, high sucrose and salt-induced IR, respectively, on cardiac expression of FATP and GLUT4 in rats.
The outcome of this study can help to explain the role of diet-induced insulin resistance in myocardial substrate transporter proteins. This study can also clarify the role of myocardial GLUT4 during high fat, high sucrose and salt-induced IR. Through this study, differential role of myocardial glucose transporter during cardiac hypertrophy-induced IR and hyperglycemic state-induced IR was established.
Forty male adult rats of Wistar strain (Rattus norvegicus), weighing between 150 and 200 g were obtained from the Experimental Animal Unit of the Faculty of Veterinary Medicine, University of Ibadan. They were housed in plastic cages placed in a well-ventilated animal house and were given ad libitum access to rat chow (Ladokun Feeds Ltd., Ibadan, Nigeria) and subjected to natural photoperiod of 12 h light–12 h dark cycle. All the animals received humane care according to the criteria outlined in the Guide for the Care and Use of Laboratory Animals prepared by the National Academy of Science (2011). Ethical regulations were followed in accordance with national and institutional guidelines for the protection of animal welfare during experiments (PHS 1996). The ethical approval number assigned for animal use in this study by Bowen University animal care and use for research committee was BUTH/REC-175.
The rats were divided randomly into 4 groups of 10 rats as follows:
Group A (control rats); rats in this group were given normal diet and clean tap water only for 6 weeks,
Group B (High fat-induced IR); rats were given 55% fat feed and clean tap water for 6 weeks, Group C (High sucrose-induced IR); rats were allowed to feed on normal rat diet and 35% sucrose in drinking water for 6 weeks,
Group D (High salt-induced IR); rats were fed with normal feed which contain 8% salt and clean tap water for 6 weeks.
3 Oral glucose tolerance test
A standardized oral glucose challenge (OGTT) was used to assess the severity of glucose intolerance by administering a 2 g/kg dose of D-glucose (0.5 g/mL) after a 12-h fasting period and measuring glucose levels 0, 30, 60, 90 and 120 min after administration using the One-touch glucometer (Abbott Diabetes Care, Alameda, CA).
3.1 Measurement of insulin in serum
Blood insulin level was measured using ELISA kit, following the manufacturing protocol of Boehringer-Mannheim Kit, Mannheim, Germany.
3.2 Blood pressure measurements
At completion of feeding the rats with high fat, sucrose and salt diets, blood pressure parameters, including systolic, diastolic, and mean arterial blood pressures, were measured, using noninvasive blood pressure monitoring machine (CODA, Kent Scientific, USA).
Standard lead II electrocardiogram was recorded in rats immobilized with xylazine–ketamine combination using a 6/7-lead ECG machine (EDAN VE-1010, Shanghai, China). The machine was calibrated at 20 mm/mV paper speed and 50 mm/s paper speed. From the electrocardiogram, parameters such as heart rate, PR interval, QRS wave duration, R-wave amplitude and QT/QTc values were determined.
3.4 Immunohistochemistry of GLUT4 and FATP/CD36
Immunohistochemistry of paraffin-embedded heart and kidney tissues was performed after the tissues were fixed with 10% formalin based on the methods described by Todorich et al. , with slight modifications as described by Alabi et al. . Briefly, paraffin sections were melted at 60 °C in the oven. Dewaxing of the samples in xylene was followed by passage through ethanol of decreasing concentrations (100–80%). Peroxidase quenching with 1% H2O2/methanol was followed by antigen retrieval performed by microwave heating in 0.01 mol/L citrate buffer (pH 6.0) to boil. All the sections were blocked in normal goat serum (10%, HistoMark, KPL, Gaithersburg, Maryland, USA) and probed with anti-GLUT4 and anti-FATP/CD36 antibodies, as appropriate (Bioss, San Diego, California, USA), 1:200 overnight at room temperature. Detection of bound antibody was carried out using biotinylated (goat anti-rabbit, 2.0 g/mL) secondary antibody and subsequently, streptavidin peroxidase (horseradish peroxidase–streptavidin) according to manufacturer’s protocol (HistoMark, KPL, Gaithersburg, Maryland, USA). The reaction product was enhanced with diaminobenzidine (DAB, Amresco, USA) for 2–3 min and counterstained with high definition hematoxylin (Enzo, New York, USA), with subsequent dehydration in ethanol. The slides were covered with coverslips and sealed with resinous solution. The immune-reactive positive expression of GLUT4 and FATP/CD36-intensive regions were viewed starting from low magnification on each slide then with 400× magnifications using a photo microscope (Olympus) and a digital camera (Toupcam; Touptek Photonics, Zhejiang, China). The measurement of immune-reactive positive expression of GLUT4 and FATP/CD36 were assessed digitally with the aid of a quantification software (ImageJ 1.48 v; National Institutes of Health, Bethesda, MD, USA). Five photomicrographs were analyzed per group for each parameter.
3.5 Statistical analysis
Statistical analysis was carried out using one-way analysis of variance (ANOVA) to compare the experimental groups, along with least significant difference (LSD) post hoc analysis, using GraphPad Prism software (version 5.0). p < 0.05 was considered statistically significant.
4.1 Effect of high fat, high sucrose and salt diet on OGTT and insulin
Rats fed with high fat, sucrose and salt diets, respectively, for 6 weeks consistently developed impaired glucose tolerance (IGT) as determined by OGTT (Fig. 1). There was a significant increase in the insulin level rats fed with high fat and salt diet compared with control group (Fig. 2). Insulin level of rats fed with high sucrose was also increased but not significant.
4.2 Effects of high fat, sucrose and salt diets on cardiovascular parameters
High fat, sucrose and salt diets had no significant effect on systolic blood pressures in rats when compared with control. However, high salt diet caused a significant increase in diastolic pressure in rats. High sucrose diet caused a significant increase in heart rate in rats compared with control, salt diet caused a significant decrease in heart rate and high fat diet had no significant effect on heart rate. High fat feed rats for six weeks had significant elongated QTc when compared with control (Table 1).
4.3 Effect of high fat, sucrose and salt diet on FATP/CD36 expression
Table 2 represents the effects of six weeks administration of high fat, high sucrose and salt diet on FATP/CD36 expression in the rat heart. Photomicrographs A–D (Fig. 3) are group representative photographs of FATP/CD36 cardiac tissue expression in rats examined by immunohistochemical staining (× 400 magnification). A represents immunohistochemical staining in control. B represents immunohistochemical staining in the salt-induced insulin-resistant group of rats. C represents immunohistochemical staining in the sucrose-induced insulin-resistant group of rats. D represents immunohistochemical staining in the high fat-induced insulin-resistant group of rats. While salt diet caused a highly significant increase in cardiac FATP/CD36 activity, high sucrose diet caused a significant decrease in cardiac FATP/CD36 activity and high fat diet had no significant effect on cardiac FATP/CD36 activity when compared with control.
4.4 Effect of high fat, high sucrose and salt diet on GLUT4 expression
Table 3 represents the effects of six weeks administration of high fat, high carbohydrate and salt diet on GLUT4 expression in the rat heart. Photomicrographs A–D (Fig. 4) are group representative photographs of GLUT4 cardiac tissue expression in rats examined by immunohistochemical staining (×400 magnification). A represents immunohistochemical staining in control. B represents immunohistochemical staining in salt-induced insulin-resistant group of rats. C represents immunohistochemical staining in sucrose-induced insulin-resistant group of rats. D represents immunohistochemical staining in high fat-induced insulin-resistant group of rats. Six weeks administration of different diet types, respectively, increased cardiac GLUT4 expression in rats significantly (p < 0.05) when compared with control, the most significant increase being in rats treated with salt diet.
The present study demonstrates the effect of different diet-induced systemic insulin resistances on myocardial substrate transport protein expression in rats. The most common indicator of systemic insulin resistance in mammals is reduced glucose utilization which manifests as reduced glucose tolerance, as measured by OGTT . OGTT is referred to as standard test for diagnosing early insulin-resistant type of diabetes . In this study, rats fed with high fat, high sucrose or salt diet developed reduced glucose tolerance as evidenced by an elevated 1-h post-load blood glucose level during OGTT. The significant increase in the level of blood insulin across all these groups further confirms the role of diets on systemic insulin resistance.
The most striking result obtained from the OGTT was the sustained higher glucose level in the salt-induced insulin-resistant rats at 120 min compared with high fat and high sucrose hyperglycemic rats. This result corroborates the study of Ogihara et al.  and Mainasara et al. , which showed that excessive consumption of salt-induced high blood pressure coexisted with insulin resistance in rats. The slight elevation of systolic pressure and diastolic pressure further agrees with these results although neither the systolic nor the diastolic blood pressure of the other diets showed any significant elevation compared with the control rats. This could probably be due to the relatively short duration of feeding the rats with the diets since other investigators have fed high sucrose diets for up to eight weeks . High salt-induced insulin resistance could be due to gradual increase in cardiac output and peripheral resistance, causing the blood pressure to increase. Since pressure overload that results from hypertension is directly related to increase in afterload of aorta and peripheral resistance , hemodynamic stress during myocardial overload could be responsible for reduced insulin sensitivity through desensitization of IRS-protein kinase Akt pathway [24, 25].
Although the impaired glucose tolerance in various diet groups in the present study was similar, their effects on the expressions of cardiac GLUT4 and FATP/CD36 activities were significantly different, suggesting that the underlying dietary factors that lead to insulin resistance may be important in determining the activity of cardiac substrate transport proteins. Under normal resting conditions, the heart expresses fatty acid transporters (FATP/CD36) and depends to a large extent on the mitochondrial oxidation of fatty acids (60–70%) for the generation of energy in the form of ATP, while glucose and lactate contribute to the remaining 30–40% [26, 27] through myocardial glucose transporter (GLUT4) uptake. However, during the postprandial state, glucose contributes to 60–70% ATP required for myocardial activity through enhanced activity of insulin . Cardiac dysfunction is known to alter myocyte energy substrate preference from predominantly fatty acid to glucose . This change in energy substrate is thought to be associated with increased activity of glucose transporter (GLUT4 and GLUT1), although GLUT4 is more predominant in the adult myocardium [30,31,32]. Indeed, the heart is known to be a metabolic omnivore and flexible in its choice of substrate for energy metabolism . Factors such as substrate availability influence the cardiac substrate of choice [12, 13] which also further buttresses the premise that the factor causing insulin resistance may also affect the expression and activity of cardiac substrate transport protein.
The significant increase in GLUT4 expression in various diet-induced insulin-resistant rats in the present study demonstrates that systemic insulin resistance increased the expression of GLUT4 in the cardiac tissue. This contradicts the results obtained from previous studies that showed a significant decrease in myocardial GLUT4 expression in rats with cardiac insulin resistance during heart dysfunction-related disease. A study conducted by Hamirani et al.  revealed that reduced glucose uptake correlates with decreased expression of GLUT4 transporter in myocardial tissue and suggests that a lowered GLUT4 expression and glucose uptake may be the molecular basis of myocardial insulin resistance in cardiac hypertrophy. A study by Afolabi et al.  further revealed that rats with cardiac hypertrophy are GLUT4 deficient. However, the observation in this study is similar to the report of Zorzano et al.  and Becker et al. . These studies revealed that cardiac GLUT4 expression was scanty until factors like hemodynamic stress and insulin activate its expression and translocation to the plasma membrane during pressure overload and volume overload. This study suggests that the effect of systemic insulin resistance on myocardial expression of GLUT4 is different from that of myocardial dysfunction-induced insulin resistance.
In addition, the outcome of this study also differentiates the effect of sucrose-induced insulin resistance on FATP from salt and fatty acid-induced insulin resistance. High fat and salt seems to increase FATP expression in myocardial tissue, while sucrose-induced IR decreased the expression. Based on this result, sucrose-induced IR appears to cause a shift in myocardial metabolic preference from fatty acid to utilization of glucose, a canonical IR metabolic pathway that is widely accepted . High fat and salt-induced IR seems to activate the expression of both GLUT4 and FATP/CD36 in the heart, and this result further suggests that salt and fatty diet-induced IR may be strong activator of AMPK, PPAR-α and mTOR01. These protein kinase and transcription factors were reported to enhance the expression and translocation of FATP and GLUT4 .
This study demonstrate that salt and not caloric excess has a more significant role in insulin resistance alteration of myocardial substrate transport protein expression in the rat.
These findings have important implications for the design of models of insulin resistance and diabetes for the study of their effects on the heart. This study also established the difference in myocardial transport protein expression between salt, fat and sucrose-induced IR.
Availability of data and materials
All data and material for this study will be provided upon request.
Fatty acid transporterCD36
Oral glucose tolerance test
Peroxisome proliferation activator receptor alpha
Adenosine monophosphate-activated protein kinase
Mammalian transcription factor of rapamycin 01
Płaczkowska S, Pawlik-Sobecka L, Kokot I, Piwowar A (2018) Estimation of metabolic factors related to insulin resistance and metabolic syndrome in young people. Scand J Clin Lab Invest 78(4):325–332
Krzewicka-Romaniuk EL, Siedlecka DA, Pradiuch A, Wójcicka G (2019) Major causes of insulin resistance. J Educ Health Sport 9(9):946–952
Jing XP, Wang WJ, Degen AA, Guo YM, Kang JP, Liu PP, Ding LM, Shang ZH, Zhou JW, Long RJ (2021) Energy substrate metabolism in skeletal muscle and liver when consuming diets of different energy levels: comparison between Tibetan and Small-tailed Han sheep. Animal 15(3):100162
Gregg E, Li Y, Wang J, Rios N, Ali M, Rolka D (2014) Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 370:1514–1523
Heather LC, Howell NJ, Emmanuel Y, Cole MA, Frenneaux MP, Pagano D, Clarke K (2011) Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis. PLoS ONE 6(10):e26326
Severson DL (2004) Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Can J Physiol Pharmacol 82(10):813–823
Luiken JJ, Nabben M, Neumann D, Glatz JF (2020) Understanding the distinct subcellular trafficking of CD36 and GLUT4 during the development of myocardial insulin resistance. Biochim et Biophys Acta (BBA)-MolBasis Dis 1866(7):165775
Sacchetto C, Sequeira V, Bertero E, Dudek J, Maack C, Calore M (2019) Metabolic alterations in inherited cardiomyopathies. J Clin Med 8(12):2195
Schulze PC, Drosatos K, Goldberg IJ (2016) Lipid use and misuse by the heart. Circ Res 118(11):1736–1751
Larsen TS, Aasum E (2008) Metabolic (in) flexibility of the diabetic heart. Cardiovasc Drugs Ther 22(2):91–95
Gambardella J, Lombardi A, Santulli G (2020) Metabolic flexibility of mitochondria plays a key role in balancing glucose and fatty acid metabolism in the diabetic heart. Diabetes 69(10):2054–2057
Schwenk RW, Luiken JJ, Bonen A, Glatz JF (2008) Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovasc Res 79(2):249–258
Glatz JF, Luiken JJ, Bonen A (2010) Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiological Rev 90(1):367–417
Jameel MN, Zhang J (2009) Myocardial energetics in left ventricular hypertrophy. Curr Cardiovasc Rev 5(3):243–250
Afolabi AO, Alabi BA, Ajike RA, Badejo JA, Micheal OS, Iwalewa EO (2021) Myocardial hypertrophy induced by nephrectomy alters cardiovascular parameters and GLUT4 expression in rats. Arch Basic Appl Med 9:161–167
Todorich B, Olopade JO, Surguladze N, Zhang X, Neely E, Connor JR (2011) The mechanism of vanadium mediated developmental hypomyelination is related to destruction of oligodendrocyte progenitors through a relationship with ferritin and iron. Neurotoxic Res 19:361–373
Alabi B, Omobowale T, Badejo J, Adedapo A, Fagbemi O, Iwalewa O (2020) Protective effects and chemical composition of Corchorus olitorius leaf fractions against isoproterenol-induced myocardial injury through p65NFkB-dependent anti-apoptotic pathway in rats. J Basic Clin Physiol Pharmacol 31(5):2019–2108
Andrikopoulos S, Blair AR, Deluca N, Fam BC, Proietto J (2008) Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab 295:E1323–E1332
Bianchi C, Miccoli R, Trombetta M, Giorgino F, Frontoni S, Faloia E (2013) GENFIEV Investigators: Elevated 1-hour post load plasma glucose levels identify subjects with normal glucose tolerance but impaired b-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study. J Clin Endocrinol Metab 98:2100–2105
Ogihara T, Asano T, Fujita T (2003) Contribution of salt intake to insulin resistance associated with hypertension. Life Sci 73(5):509–523
Mainasara AS, Isa SA, Dandare A, Ladan MJ, Saidu Y, Rabiu S (2016) Blood pressure profile and insulin resistance in salt-induced hypertensive rats treated with camel milk. Mediterr J Nutr Metab 9(1):75–83
Kendig MD, Westbrook RF, Morris MJ (2019) Pattern of access to cafeteria-style diet determines fat mass and degree of spatial memory impairments in rats. Sci Rep 9:13516. https://doi.org/10.1038/s41598-019-50113-3
Qi Y, Xu Z, Zhu Q, Thomas C, Kumar R, Feng H (2013) Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38alpha MAPK during insulin resistance. Diabetes 62:3887–3900
Laustsen PG, Russell SJ, Cui L, Entingh-Pearsall A, Holzenberger M, Liao R, Kahn CR (2007) Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Mol Cell Biol 27:1649–1664
Gimeno RE, Ortegon AM, Patel S, Punreddy S, Ge P, Sun Y (2003) Characterization of a heart-specific fatty acid transport protein. J Biol Chem 278:16039–16044
Stanley WC, Chandler MP (2002) Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Failure Rev 7:115–130
Bertrand L, Horman S, Beauloye C, Vanoverschelde JL (2008) Insulin signaling in the heart. Cardiovasc Res 79:238–248
Stanley WC, Recchia FA, Lopaschuk GD (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85:1093–1129
Snyder J, Zhai R, Lackey AI, Sato PY (2020) Changes in myocardial metabolism preceding sudden cardiac death. Front Physiol 11:640. https://doi.org/10.3389/fphys.2020.00640
Wang T, Wang J, Hu X, Huang XJ, Chen GX (2020) Current understanding of glucose transporter 4 expression and functional mechanisms. World J Biol Chem 11(3):76–98
Hamirani YS, Kundu BK, Zhong M, McBride A, Li Y, Davogustto GE (2006) Non-invasive detection of early metabolic left ventricular remodeling in systemic hypertension. Cardiology 133:157–162
Chadt A, Al-Hasani H (2020) Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. Pflugers Arch – Eur J Physiol 472:1273–1298. https://doi.org/10.1007/s00424-020-02417-x
Zorzano A, Sevilla L, Camps M, Becker C, Meyer J, Kammermeier H (1997) Regulation of glucose transport, and glucose transporters expression and trafficking in the heart: studies in cardiac myocytes. Am J Cardiol 80:65A-76A
Becker C, Sevilla L, Tomàs E, Palacin M, Zorzano A, Fischer Y (2001) The endosomal compartment is an insulin-sensitive recruitment site for GLUT4 and GLUT1 glucose transporters in cardiac myocytes. Endocrinology 142:5267–5276
Wende AR, Brahma MK, McGinnis GR, Young ME (2017) Metabolic Origins of Heart Failure. JACC Basic Transl Sci 2:297–310
This research was done without specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Ethics approval and consent to participate
All of the experiments were conducted according to the approved guidelines set by Bowen University Animal Care and Use Research Ethics Committee, which is in agreement with the ‘Guide for the Care and Use of Laboratory Animals’ prepared by the National Academy of Science and published by the National Institutes of Health. The ethical approval number assigned for animal use in this study was BUTH/REC-125.
Consent to participate
Authors declare no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Afolabi, O.A., Alabi, B.A. & Oluranti, O. Diet-induced insulin resistance altered cardiac GLUT4 and FATP/CD36 expression in rats. Beni-Suef Univ J Basic Appl Sci 11, 131 (2022). https://doi.org/10.1186/s43088-022-00312-1